The funny thing is
@verysmallcap, I've been a holder, and have been adding to my position, through everything you mentioned above!!
Sheez, when i get more money I'm gonna buy more!!!
So don't worry about me, I've been deluded enough to be accumulating while others are scared, its a legitimate tactic but can often end in losses if I'm not careful.
As this thread is "pro's and cons for newbies", ill address some of the things you have listed just to balance this all out (as some is true but some is assumptions, opinions or incorrect information).
I just wanna say one word about the companies performance in recently: Bergen
Now that's out of the way . .
1. True: UUV ran out of money recently but was able to secure more, through a loan and those CR's. We don't have long left and each quarter will be "do or die", moving forward sales are a must, we're over unmerited CR's. Bergen.
2. Untrue: A cursory check of the Top 20 IPO investors from 20/4/17 and the current list as of 11/02/19 reveals the only major IPO holder's to leave were UBS noms and JPM noms, who have removed their 3% weighting of a combined 3,750,000 units. Some other original IPO Top 20's have been buying more. Largely Top 20 has barely changed, and generally, holdings have gone up.
I believe you may be refering to Durval Tavares no longer holding a position on the board. This was due to his inexperience as a listed company manager. However, all of his holdings of the companies stock remain intact. He developed the technology. This was to make way for Miss Million and her BAE experience.
3. True: That loan money was required after the two previous CR's fell short by $200,000. Was it Bergen that helped out with that $200,000? I forget.
In more recent news, board members and new joint secretaries were
happy to receive shares in lieu of money as compensation, a good sign that those inside see the stock being worth their wages.
4. True: It was "do or die" as far is interest from the general market ASX was concerned, and they have diluted quite heavily since taking a military focus a year ago.
As we've established, those "failed" to market CR's were for operating costs for the forward estimates, and we, the market, were not happy. You would also do well to remember that similar CR to sophisticated investors only (10/7/19) was fully subscribed.
Millionaires with more money than us were happy to get in after they saw our rejections and objections of those earlier CR's!! (or saw it as a great opportunity to park money as a write off for a later date, depends how you see it.)
5. Untrue speculating: You cant claim to know why the order is when its for, and the reasons behind it. $500k cash on hand is true, but attempting to paint the order itself as a sign of company weakness is just plain downrampin'.
6. True: They are only down to one engineer.
7. True: They are short on cash .As we've seen, a recent trend has been to offer employees shares as compensation, and so far everyone has accepted. This removes the cash shortage aspect and adds a dilution aspect. To me, overall, people accepting stock as compensation, given recent stock performance, is a good sign. Sales will offset further costs.
8. True: All of this is fine, its just a risky bet.
People need to be diligent and decide if the risk v reward profile is right for them, but they need accurate information.
9. Untrue: An "old" patent is 21 years old. A patent is 20 years old or younger. This company patented 5 technologies thanks to Durval Tavares.
The patents relate to the design and shape, internal power management, navigational swarming, internal sampling containers and light/camera housing.
10. Opinion: I wouldn't say UUV is "way behind", but the market is tight. I was referring to my target for this companies market cap as $60 million. The projected sales value in the sector is $5.2 billion by 2022, globally. Draper and Riptide collaborated for a UUV's, which was bought out by BAE. Teledyne is successful in the space. Raytheon has recieved the largest contract in the space to-date.
To suggest Aquabotix will not be able to achieve sales in this space is just downrampin'. We have contacts and are well positioned, you make it sound like there's no chance, which is opinion.
We may even be a buyout target for our "big buddy", Thales, who can then compliment their system with Aquabotix UUV's.
11. Untrue: This money was for the development of specific capabilities the USN expressed interest in, and included with the earlier contract was contact time on-base with the USN. You simply do not just get USN money if you are techless chumps who wont leave them alone. The value of these contracts has been increasing, another good sign. They are interested in what we can do.
12. Opinion, not fact: I don't know if having a retired Rear Admiral, who served in the USN (and commanded a ship) on your board, is praying for US luck. Kinda seems like making our own luck, really.
But between Miss Million (BAE) and Adm. J Cohen (USN) we ain't praying in the US, we are asking what they need, they tell us and give us money to attempt it.
This will bear fruit in the long term.13. Opinion, not fact. Credit raises will be coming. They will need staff to get production going harder, but you weren't even sure what patents they held, how do you know they need more? Is the current product enough?
14. Opinion, not fact. We may get bought out as a shell after failing, we may be bought out by Thales through succeeding. We are short on cash, but we just landed our biggest sale to date. It could go either way from here.
So i just wanted to separate opinion from fact, in this thread for new investors, and encourage everyone to DYOR.
It certainly isn't as bad as some paint it, but has the potential to go either way!
(20min delay)